(19)
(11) EP 0 425 536 A1

(12)

(43) Date of publication:
08.05.1991 Bulletin 1991/19

(21) Application number: 89907981.0

(22) Date of filing: 14.06.1989
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 17( . )
A61K 39/ 395( . )
A61P 37/ 04( . )
C07K 14/ 52( . )
C12P 21/ 02( . )
A61K 38/ 00( . )
A61K 38/ 20( . )
A61P 7/ 00( . )
C07K 14/ 00( . )
C07K 14/ 54( . )
C12R 1/ 865( . )
(86) International application number:
PCT/US1989/002599
(87) International publication number:
WO 1990/001039 (08.02.1990 Gazette 1990/04)
(84) Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE

(30) Priority: 20.07.1988 US 19880221699

(71) Applicant: IMMUNEX CORPORATION
Seattle Washington 98101 (US)

(72) Inventors:
  • ANDERSON, Dirk, M.
    Seattle, WA 98133 (US)
  • COSMAN, David, J.
    Seattle, WA 98102 (US)
  • PRICE, Virginia, L.
    Seattle, WA 98102 (US)

(74) Representative: Sheard, Andrew Gregory, et al 
Kilburn & Strode 30, John Street
London WC1N 2DD
London WC1N 2DD (GB)

   


(54) NONGLYCOSYLATED HUMAN INTERLEUKIN-3 COMPOSITIONS